Clinical Trial

A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants

Name: A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants — clinical trial record (NCT07662057)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is assess the safety and tolerability of AB102 and characterize the pharmacokinetics (PK) profile of AB102 after single and multiple ascending oral dose(s).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-18.

Trial Details

NCT Number	NCT07662057
Lead Sponsor	Arcus Biosciences, Inc.
Conditions	Healthy Volunteers
Enrollment	130 participants
Start Date	2026-07
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-25